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ABSTRACT  The COS-7 cell line, derived from the kidney cells of African green monkeys, is 
often used in studies involving the production of recombinant proteins. Using a focused DNA 
microarray (EstrArrayTM), we examined the expression profile of estrogen-responsive genes in 
COS-7 cells which over-express the estrogen receptorα. This was undertaken via  transfection 
of the expression vector in the absence or presence of 17β-estradiol (E2). The genes which 
were up- or down-regulated over 1.5-fold (+E2/－E2 ratio or －E2/+E2 ratio, respectively) in the 
17β-estradiol-stimulated COS-7 cells were shown. The data was compared with that of the 
MCF-7 breast cancer cells. They were mostly the members necessary for gene expression and 
metabolism of amino acids and polynucleotides. 
(Accepted on May 1, 2009)




Department of Biochemistry, Kawasaki Medical School, 
577 Matsushima Kurashiki, 701-0192, Japan
Phone : 81 86 462 1111
Fax : 81 86 462 1199
E-mail : ikeda@bcc.kawasaki-m.ac.jp
INTRODUCTION
   The estrogen receptors (ERs) belong to a superfamily 
of nuclear receptors including those of steroid, 
thyroid hormones, vitamin D and retinoic acid. 
Estrogen receptors α and β generally mediate the 
biological effects of estrogen in their target cells 
by binding to estrogen response elements (EREs) 
in the promoter region of the target genes. Ligand-
dependent transcriptional activation is mediated by 
the interaction of nuclear receptors with coactivators 
such as SRC-1/p160, p300/CBP, ARA70, Tip60 and 
RIP140. This kind of coactivator recruits histone 
acetyltransferase (HAT) or bears HAT activity 
within itself. The recruitment of HAT allows the 
local decondensation of chromatin, followed by the 
binding of other types of coactivators. Thus, these 
coactivators facilitate the transcriptional process. 
In the absence of ligands, certain kinds of nuclear 
receptors bind to corepressors, which in turn recruit 
histone deacetylase (HDAC). The chromatin-
modifying complexes, chromatin-remodeling 
complexes,  and the HAT or HDAC regulate 
chromatin structures and gene transcription. The 
estrogen receptors can modulate the transcription 
of genes by various means including the classical 
interaction of activated receptors with estrogen 
response elements on the DNA and the indirect 
effects of estrogen receptors on transcription 
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interactions through protein-protein interaction with 
Sp1, AP-1 and NF-κB. The non-genomic effects of 
estrogen via membrane receptors may be involved 
in the control of apoptosis, cell proliferation, and 
differentiation１－４）.
   Two subtypes of COS cell lines, COS-1 and COS-
7 cells, were obtained by transformation of an 
origin-defective mutant of Simian virus 40 (SV 40) 
which codes for the wild-type T antigen to the CV-1 
cells derived from the African green monkey kidney 
cells. The COS cell lines have been used to produce 
recombinant proteins５）. In estrogen receptor-
negative COS-7 cells, transiently transfected with 
the reporter plasmid bearing ERE in a certain 
promoter, 17β-estradiol (E2) could induce promoter 
activities in the cells after cotransfection with 
expression vectors of the estrogen receptors. The 
experimental system using COS-7 cells cotransfected 
both with reporter plasmids and expression vectors 
of the estrogen receptors has long been used in our 
laboratory３,４） and others６,７）. Except for the reporter 
plasmids above, however, it is unclear what genes 
could be up- or down-regulated by 17β-estradiol 
in the COS-7 cells over-expressing the estrogen 
receptor α .
   A DNA microarray has been developed to examine 
the gene expression in high-throughput and time/
cost-saving fashion８,９）. Expression profiling is one 
of the most advanced transcriptomic techniques 
available to monitor and evaluate the effect of 
chemicals.
   In the present study, utilizing a focused DNA 
microarray of newly selected estrogen-responsive 
genes, we examined the expression profiling of 
estrogen-responsive genes in COS-7 cells which 
were over-expressing the estrogen receptorα. We 
found several genes were up- or down-regulated 
by 17β-estradiol in the COS-7 cells which were 
cotransfected both with the reporter plasmid and the 
expression vector of the estrogen receptorα. 
MATERIALS AND METHODS 
Construction of plasmids
   The construction of the expression vector of 
human-origin (h)ERα, pcDNA-hERα, the reporter 
plasmid for monitoring the transcriptional activation 
ability of the estrogen receptor, pEREtkCAT, and 
the expression vector of β-galactosidase (β-gal), 
pcDNAβ-gal, was described previously３,４）.
Cell culture
   COS-7 cells were purchased from The Institute of 
Physical and Chemical Research (RIKEN, Wako, 
Japan). They were maintained in Dulbecco's modified 
Eagle's minimal essential medium (DMEM, Sigma 
Co., St. Louis, MO, USA) supplemented with 10% 
fetal bovine serum (FBS) (Medical & Biological 
Laboratories Co., Nagoya, Japan). The cells were 
maintained in 5% CO2 at 37 °C.
Transfection of plasmids
   The medium for COS-7 cells in a screw-capped 
flask (25 cm2) was replaced by phenol red-free 
MEM (Nissui Pharmaceutical Co., Tokyo, Japan) 
supplemented with a 10 % dextran-coated charcoal-
treated (DCC) FBS 48 h before transfection３）. 
The COS-7 cells were cotransfected with plasmids 
by using LipofectamineTM 2000 (Invitrogen Co., 
Groningen, The Netherlands) as indicated (Fig. 1), 
and incubated for 48 h in the absence or presence 
of 10-7 M 17β-estradiol after transfection. The 
cells were then submitted to a chloramphenicol 
acetyltransferase assay and DNA microarray assay.
Chloramphenicol acetyltransferase assay
   The chloramphenicol acetyltransferase (CAT) 
assay and the β-gal assay were performed as 
mentioned previously３,４）. Briefly, a FAST CAT 
Yellow (deoxy) CAT Assay Kit (Molecular Probes, 
Eugene, OR, USA) was utilized in the CAT 
assay. The cell extract was prepared according 
to the manufacturer's manual. A portion of the 
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cell extract was incubated with a fluorescent 
deoxychloramphenicol substrate and acetyl CoA 
at 37 °C for 2 h. Quantification of the acetylated 
derivative and the substrate was undertaken by 
measuring the absorbance with a fluorescence 
spectrophotometer, model F-3010 (Hitachi Co., 
Tokyo, Japan). For the β-gal assay, the other portion 
of the cell extract was incubated with o-nitrophenyl 
β-galactopyranoside at 37 °C for 30 min. The 
relative CAT activities were calculated according to 
the manufacturer's manual and normalized by β-gal 
activities. The background CAT activity of the cells 
cotransfected with the parental plasmid, pcDNA3 
(Invitrogen Co.) instead of pcDNA-hERα was 
subtracted from each value of CAT activity.
cDNA microarray assay
   A focused cDNA microarray (EstrArrayTM) was 
manufactured by InfoGenes Co., Ltd. (Kashiwa, 
Japan) through mechanical spotting of cDNA 
fragments (500  bp to 1 .5  kb) for 203  genes 
including a set of 172 estrogen-responsive genes 
as described previously10）. Briefly, the 172 genes 
were selected based on the results from expression 
profiling of approximately 20 ,000  genes of 
MCF-7 breast cancer cells using Human U95A 
oligonucleotide probe arrays (Affymetrix, Santa 
Clara, CA, USA) and a Human UniGEM ver. 2.0 
microarray system (IncyteGenomics, Palo Alto, 
CA, USA). They consisted of 108 up- and 64 down-
regulated genes in the 17β-estradiol-stimulated 
MCF-7 cells. EstrArrayTM contains a total of 203 
genes including of 172 estrogen-responsive genes, 
three expression marker genes and 28 control genes 
used for normalization of Cy3/Cy5 ratios of signal 
intensities. 
   The COS cells were cotransfected with pcDNA-
hERα (0.01μg) and pEREtkCAT (1μg) in a 
flask (25 cm2) and incubated as mentioned above 
(designated as COS-7  + ERα) cells. For the 
EstrArrayTM assay, total RNA was isolated from the 
cells according to the manufacturer's instruction 
using ISOGEN (Wako Pure Chemical, Tokyo, 
Japan). Antisense RNA (aRNA) was prepared 
according to the manufacturer's protocol from 5 mg 
of total RNA using a RiboAmp RNA Amplification 
Kit (Takara Bio, Otsu, Japan). cDNA labeled with 
either Cy3 or Cy5 was synthesized from 4 μg of 
aRNA which was derived from 17β-estrtadiol-
treated cells (corresponding to Cy3) or 17β
-estrtadiol-untreated cells (Cy5) using an Atlas 
PowerScript Fluorescent Labeling Kit (Takara 
Bio, Otsu, Japan). The labeled cDNA probes were 
purified using a CyScribe GFX Purification Kit (GE 
Healthcare, Tokyo, Japan) and then utilized for co-
hybridization onto the EstrArrayTM overnigh at 65 
°C in a hybridization buffer (5 x SSC containing 
0.5% SDS; 1x SSC consists of 150 mM sodium 
chloride and 15 mM sodium citrate). The slides 
were washed for 5 min at room temperature with 
2x SSC/0.2% SDS, followed by washing for 5min 
with 0.2x SSC/0.2% SDS and with 0.2x SSC. The 
slides were scanned using a ChipReader (Virtek, 
Ont., Canada) and the image was analyzed with 
IPLab software (Scanalytics, Fairfax, VA, USA). 
The EstrArrayTM assay was performed twice using 
independent cell cultures.
Data analysis
   For data processing, we used the values of Cy3- 
and Cy5-signals when their intensities were equal 
to or greater than 30, and their corresponding 
signal areas were equal to or greater than 50. The 
calculation of expression ratios was carried out 
using Microsoft Excel software. The average signal 
intensities for Cy3 or Cy5 between duplicated spots 
were calculated and the ratio of the mean signal 
intensity for Cy3 to that of Cy5 was then calculated 
for each gene. For normalization, the ratios of Cy3 
to Cy5 signal intensities for 28 control genes were 
averaged after removing the genes whose signal 
areas for either Cy3 or Cy5 were less than 100. 
Finally, the ratios of Cy3/Cy5 for all genes were 
normalized by dividing the ratios with the mean 
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Cy3/Cy5 ratio for 28 control genes.
RESULTS AND DISCUSSION
Transcriptional activation ability of the estrogen 
receptor α over-expressed in the COS-7 cell
   First we evaluated whether the estrogen receptor 
α over-expressed in COS-7 cells, could mediate 
transcriptional activities in a cell. The COS-7 cells 
were transiently cotransfected with the reporter 
plasmid bearing EREs in the tk promoter and the 
expression vector of the estrogen receptor α, 
pcDNA-hERα, as shown in the bottom of Fig. 1 
and incubated in the absence or presence of 17β 
-estradiol. In the presence of 17β-estradiol, the 
estrogen receptor α enhanced the transcriptional 
activity (relative CAT activity) by 167-fold over 
activity in the absence of 17β-estradiol. Therefore, 
the estrogen receptor α was transcriptionally active 
in the COS-7 cells 
Focused DNA microarray (EstrArrayTM) analysis
   By using a focused DNA microarray (EstrArrayTM), 
we examined the genes up- or down-regulated in the 
presence or absence of 17β-estradiol in the COS-
7 cells which over-express the estrogen receptor α 
by transient transfection of the expression vector of 
the estrogen receptor α, pcDNA-hERα, as shown 
in the bottom of Fig. 1. The genes which were up- 
or down-regulated over 1.5-fold (+E2/－E2 ratio or
－E2/+E2 ratio, respectively) in the 17β-estradiol-
stimulated COS-7 cells were shown in Table 1. 
The data of COS-7 cells was compared with that 
of the MCF-7 cell (Table 1). They were mostly 
the members necessary for gene expression and 
metabolism of amino acids and polynucleotides. 
Transcription elongation factor A is necessary for 
RNA chain elongation11, 12）. Solute carrier family 7 
members 11 and 5 are for amino acid transport13）. 
Methylenetetrahydrofolate dehydrogenase (NADP+ 
dependent) 2, methylenetetrahydrofolate cyclohydlase 
is for folic acid derivative biosynthesis14）. The 
function of retinoblastoma binding protein 8 is a 
potential modulator of transcriptional regulation of 
BRACA1, DNA repair and cell cycle checkpoint 
control15）. Phorbol-12-myristate-13-acetate-induced 
protein 1 promotes activation of caspases and 
apoptosis16）. Thus the growth of COS-7 cells could 
be inhibited. The estrogen receptor α influenced not 
only gene expression of the transient transfected 
reporter gene bearing ERE in the tk promoter (Fig. 
1), but also the intrinsic gene expression (Table 1).  
Comparison between the genes responding to 17β
-estradiol in COS-7 cells and  MCF-7 cells
   The mean magnitudes of up- or down-regulation 
of genes in response to 17β-estradiol in the COS-
7 cells which over-express the estrogen receptor α 
Fig. 1. Evaluation of transcriptional activation ability of 
estrogen receptor α over-expressed in COS-7 cells by the 
reporter plasmid bearing ERE in the tk promoter   The COS-
7 cells were transiently transfected with plasmids as indicated 
at the bottom. pcDNA3 (a parental plasmid of pcDNA-
hERα) was added to obtain the same input DNA amount. 
pcDNAβ-gal was cotransfected to normalize transfection 
efﬁciency. After transfection, the cells were incubated for 48 
h in the absence (No.1) or presence (No.2) of 10-7 M 17β
-estradiol (E2). In each graph, the background CAT activity 
values in cells transfected with pcDNA3 instead of pcDNA-
hERα were subtracted from each CAT activity values. The 
CAT activity in the presence of 17β-estradiol (No.2) is 
represented as 100 %. Values are the means ± SD of three 
independent experiments.
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were arranged in order from high expression (left) 
to low expression (right). They were compared 
Table 1.　The genes which were up- or down-regulated over 1.5-fold in response to 17β-estradiol in the COS-7 cells which 
over-express the estrogen receptor α By using a focused DNA microarray (EstrArrayTM), we examined the genes up- or down-
regulated in the COS-7 cells which over-express the estrogen receptor α by transient transfection of plasmids as shown in the 
bottom of Fig. 1. The genes which were up- or down-regulated over 1.5-fold in means of independent duplicate experimental 
data [+17β-estradiol (E2)/－E2 ratio or －E2/+E2 ratio, respectively] were shown and compared with the results of MCF-7 cell (the 
data by InfoGenes Co., Ltd.). The results (fold induction) are shown as r; the ratio of Cy3 signal intensity from 17β-estradiol-
treated cells to Cy5 from 17β-estradiol-untreated cells. r = Cy3/Cy5 (in the case of 1 ≦ Cy3/Cy5) or r = -Cy5/Cy3 (in the case 
of Cy3/Cy5<1) 
(fold induction)











 1.9  1.7  1.8  2.2
NM
006756
TCEA1 Transcription elongation factor A (SII), 1  2.1  1.6  1.8  1.8
NM
014331
SLC7A11 Solute carrier family 7 (cationic amino acid
transporter, y+ system) member11






 1.5  1.4  1.5  3.3
NM
002894 
RBBP8 Retinoblastoma binding protein 8 -1.2 -1.7 -1.5  5.2
NM
003486
SLC7A5 Solute carrier family7 (cationic amino acid
transporter, y+ system) member5
-1.3 -1.9 -1.5  4.0
Acc.No. : Accession No. of GeneBank.
to the gene expression profile of a human breast 
cancer cell line, MCF-7 cells expressing an intrinsic 
estrogen receptor α (InfoGenes Co., Ltd.) (Fig.2). 
The genes which were up- or down-regulated in 
the COS-7 cells which over-express the estrogen 
receptor α (red vertical bars in the graph) were 
very different from the genes which were up- or 
down-regulated in MCF-7 cells which express an 
intrinsic estrogen receptor α (blue vertical bars in 
the graph). The previously identified estrogen-
responsive genes, No.1: PDZK1, No.2: EGR3, 
and No.3: IGFBP510） (indicated by the arrows and 
the numbers in the graph), showed prominent 
differences in estrogen-responsiveness between the 
two cell lines. In the COS-7 cells, in the presence of 
17β-estradiol, the estrogen receptor α influenced 
mainly the gene expression of the reporter gene 
(CAT) bearing EREs in the tk promoter.
   The regulation mechanisms for the genes 
on EstrArrayTM were not fully investigated. The 
expression of genes under the control of eukaryotic 
promoters may depend on the chromatin structure 
surrounding DNA and the accessibi l i ty  of 
the transcription factors to the promoter. The 
Fig. 2. Comparison between the genes responding to 17β 
-estradiol in COS-7 cells and the corresponding genes of 
MCF-7 cells    The genes which were up- or down-regulated 
in the COS-7 cells (red vertical bars in the graph) over-
expressing the estrogen receptor α by transfection of the 
expression vector pcDNA-hERα were arranged according 
to order from high expression values (left) to low expression 
values (right). They were compared with the corresponding 
genes in the presence or absence of 17β-estradiol in a human 
breast cancer cell line, MCF-7 cells (blue vertical bars in 
the graph) expressing an intrinsic estrogen receptor α. The 
y-axis represents log2Cy3/Cy5. Cy3: the value from the 17
β-estradiol-treated cells and Cy5: the value from the 17β
-estradiol-untreated cells.  The previously identiﬁed estrogen-
responsive genes, No.1: PDZK1, No.2: EGR3, No.3: 
IGFBP5, were indicated by the arrows and the numbers10）.
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methylation of the promoter has been demonstrated 
to correlate with gene silencing17）. The COS-7 cell is 
not a target cell for estrogen. The cell does not have 
intrinsic estrogen receptors and was assumed not 
to have the machineries to respond to the estrogen 
receptor signal. Many of the estrogen-responsive 
genes in MCF-7 cells might require cofactors or 
other proteins to control chromatin remodeling in 
responding to estrogen, but some of these factors 
may not have been available in COS-7 cells. The 
effects of estrogen on the reporter gene (CAT) 
bearing ERE in the tk promoter were extremely 
amplified (Fig. 1). The genomic EREs in COS-
7 cells may not have been exposed to the estrogen 
receptor to bind, and many genes did not participate 
in biological effects. The estrogen receptors can 
modulate transcription of reporter genes in various 
modes including the estrogen receptor-ERE interaction 
and the protein-protein interaction as mentioned 
above. The effects of estrogen observed in this 
study might be caused by estrogen receptor-protein 
interactions, but not by interactions between 
estrogen receptors and genomic EREs. The estrogen 
receptor expressed in the COS-7 cells may exercise 
positive or negative effects on the metabolism of 
amino acids and polynucleotides, cell cycles or 
apoptosis (Table 1). The effects of estrogen on MCF-
7 cells were more numerous, more complicated, and 
more potent (Fig. 2). In summary, estrogen causes 
the cell growth in MCF-7 cells expressing intrinsic 
estrogen receptor α18）, but not in the COS-7 cells 
with the estrogen receptor α over-expressed (data 
not shown).  
   A focused DNA microarray (EstrArrayTM) containing 
estrogen-responsive genes from human cells was 
previously developed by some of the authors. They 
analyzed the effects of estrogens, phytoestrogens, 
and estrogen antagonists and reported that all genes 
examined showed similar responses in both DNA 
microarray and RT-PCR analysis. This confirms the 
results of the DNA microarray assay19）. Others also 
demonstrated that the accuracy of data for a focused 
DNA microarray based on RT-PCR analysis, thus 
confirming the reliability of data where gene 
expressions were up- or down-regulated 1.3-fold 
as compared to the control data20, 21）. The gene-
expression analysis using a focused microarray is 
accurate enough to examine whether the selected 
genes are up- or down-regulated over 1.5-fold, 
and the cost and time needed for the analysis are 
effectively reduced.
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